p53, the cellular gatekeeper for growth and division - PubMed (original) (raw)

Review

p53, the cellular gatekeeper for growth and division

A J Levine. Cell. 1997.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• The molecular perspective: p53 tumor suppressor.
  Goodsell DS. Goodsell DS. Oncologist. 1999;4(2):138-9. Oncologist. 1999. PMID: 10337384 No abstract available.
• [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
  Mendoza-Rodríguez CA, Cerbón MA. Mendoza-Rodríguez CA, et al. Rev Invest Clin. 2001 May-Jun;53(3):266-73. Rev Invest Clin. 2001. PMID: 11496714 Review. Spanish.
• [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
  Hainaut P. Hainaut P. Bull Cancer. 2000 Jan;87(1):11-8. Bull Cancer. 2000. PMID: 10673626 French. No abstract available.
• The p53 tumour suppressor protein.
  Hickman ES, Helin K. Hickman ES, et al. Biotechnol Genet Eng Rev. 2000;17:179-211. doi: 10.1080/02648725.2000.10647992. Biotechnol Genet Eng Rev. 2000. PMID: 11255666 Review. No abstract available.
• [The tumor suppressor gene p53 (part one). Structure, function and mechanisms of inactivation].
  Martin A. Martin A. Ann Pathol. 1995;15(3):178-83. Ann Pathol. 1995. PMID: 7639853 Review. French. No abstract available.

Cited by

• Losartan and enalapril maleate differently influence SARS-CoV-2-infected vero cells.
  Majolo JH, Gonçalves JIB, Souza RP, González LC, Sperotto N, Silveira MD, Oliveira SD, Bizarro CV, Machado P, Basso LA, Souza APD, Oliveira JR, Ferreira CAS. Majolo JH, et al. Sci Rep. 2024 Oct 22;14(1):24801. doi: 10.1038/s41598-024-76657-7. Sci Rep. 2024. PMID: 39433817 Free PMC article.
• Suppression of Poly(rC)-Binding Protein 4 (PCBP4) reduced cisplatin resistance in human maxillary cancer cells.
  Ito Y, Narita N, Nomi N, Sugimoto C, Takabayashi T, Yamada T, Karaya K, Matsumoto H, Fujieda S. Ito Y, et al. Sci Rep. 2015 Jul 21;5:12360. doi: 10.1038/srep12360. Sci Rep. 2015. PMID: 26196957 Free PMC article.
• Programmed cell death 6, a novel p53-responsive gene, targets to the nucleus in the apoptotic response to DNA damage.
  Suzuki K, Dashzeveg N, Lu ZG, Taira N, Miki Y, Yoshida K. Suzuki K, et al. Cancer Sci. 2012 Oct;103(10):1788-94. doi: 10.1111/j.1349-7006.2012.02362.x. Epub 2012 Aug 7. Cancer Sci. 2012. PMID: 22712728 Free PMC article.
• ΔNp63α transcriptionally represses p53 target genes involved in the radiation-induced DNA damage response : ΔNp63α may cause genomic instability in epithelial stem cells.
  Kudo KI, Tsuyama N, Nagata K, Imaoka T, Iizuka D, Sugai-Takahashi M, Muramatsu M, Sakai A. Kudo KI, et al. Radiat Oncol. 2022 Nov 15;17(1):183. doi: 10.1186/s13014-022-02139-7. Radiat Oncol. 2022. PMID: 36380314 Free PMC article.
• Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program.
  Kang MH, Reynolds CP, Kolb EA, Gorlick R, Carol H, Lock R, Keir ST, Maris JM, Wu J, Lyalin D, Kurmasheva RT, Houghton PJ, Smith MA. Kang MH, et al. Pediatr Blood Cancer. 2016 Oct;63(10):1744-52. doi: 10.1002/pbc.26064. Epub 2016 May 30. Pediatr Blood Cancer. 2016. PMID: 27238606 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal